TP53 and neoplasm: This in turn allows for simpler dual strand whole exon coverage of tumour suppressors such as TP53 and APC by avoiding the risk of opposing primers forming non-specific PCR products while allowing for reductions in PCR cycles from increased amplification efficiencies.